Search results
Barclays cuts Gilead Sciences stock target, reiterates Equalweight rating By Investing.com
Investing.com· 47 minutes agoOn Monday, Barclays made adjustments to its outlook on Gilead Sciences (NASDAQ:GILD), a...
Barclays lowers AbbVie shares target on Humira sales erosion concerns By Investing.com
Investing.com· 4 hours agoOn Monday, Barclays made an adjustment to its outlook on AbbVie (NYSE:ABBV) shares, reducing the...
Barclays' Cau Says Buybacks Should Help This Market
Bloomberg· 4 hours agoBarclays' Head of European Equity Strategy Emmanuel Cau discusses buybacks, UK growth and shares his views on the Fed rate cut debate. Cau joined Guy...
Analyst Report: Barclays PLC
Morningstar Research via Yahoo Finance· 11 hours agoBarclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments; U.K. (38% of profit before tax) and International (71% of PBT). In ...
Mexican Companies Are Lining Up to Sell Shares, Barclays Says
Bloomberg· 3 days agoMexican companies are pushing ahead with plans to sell shares, seeking to tap renewed interest from...
Barclays says recession fears are returning By Investing.com
Investing.com· 3 days agoBarclays strategists said on Friday that stock investors were gearing up for a mid-to-late...
Bankers Doing Bond Deals Jolted by New Era of Issuer Clauses
Bloomberg via Yahoo Finance· 3 hours ago(Bloomberg) -- Message to bond underwriters: Some big customers are sizing up your ESG...
Barclays’s latest rating for WFRD stock – Knox Daily
Knox Daily· 7 hours agoAs a result of the transaction, Sandhu Depinder now holds 2,536 shares, worth roughly $0.32 million. Barclays initiated its Weatherford International plc [WFRD] rating to ...
Barclays Cuts Accolade (NASDAQ:ACCD) Price Target to $11.00
ETF DAILY NEWS· 11 hours agoAccolade (NASDAQ:ACCD – Free Report) had its target price reduced by Barclays from $13.00 to $11.00 in a report published on Friday, Marketbeat reports. Barclays& ...
Barclays Trims Intel (NASDAQ:INTC) Target Price to $40.00
ETF DAILY NEWS· 6 hours agoIntel (NASDAQ:INTC – Free Report) had its price target lowered by Barclays from $44.00 to $40.00 in a research report sent to investors on Friday, Benzinga reports.
